Advance academic research with real-world evidence
Explore patient journeys, treatment patterns, and health outcomes over time with MarketScan’s longitudinal real-world data. Build evidence to supplement clinical trials, guide research priorities, and strengthen grant proposals.

SUPPLEMENT CLINICAL TRIALS
How research teams are enhancing and accelerating studies
-
A large university needed broader evidence to strengthen its research
-
The challenge: broader study populations, longer follow-up, national benchmarks for local findings, and evidence for competitive grant proposals.
-
MarketScan’s longitudinal real-world data supplemented clinical trials, revealed longer-term outcomes, and strengthened proposals to help secure research funding.
MarketScan solutions
Quickly assess real-world data fit
Use AI-powered, plain-language search to see whether MarketScan Research Databases can support your analytics needs – no coding required.
Real-world data
Use conclusive real-world data to enhance your research. MarketScan offers real-world datasets, experts that drive research or regulatory-grade studies, and intuitive applications.
Streamlined cloud tooling
Enhance team efficiency and collaboration by leveraging a no-code application and a scalable cloud environment on Snowflake.
Expert services
Draw insights and guidance from experts with deep experience in epidemiology, regulatory approvals, and health economics outcomes research (HEOR).
RESOURCES
Learn more about MarketScan
Fueling academic research with real-world data
Learn how one university is using longitudinal, real-world data to supplement clinical trials and guide research priorities and funding.
AI-powered MarketScan Snapshot speeds real-world data feasibility
The complimentary AI-powered capability helps teams evaluate patient population counts and see whether MarketScan RWD is fit for their evidence needs.
Unlock value with MarketScan’s advanced data linking
MarketScan and Biodesix experts explored how advanced data linking drives deeper understanding, better decision‑making, and measurable organizational value.